ZA978334B - Use of IFG-I for the treatment of kidney disorders renal insufficiencies steriod toxicity and related indications - Google Patents
Use of IFG-I for the treatment of kidney disorders renal insufficiencies steriod toxicity and related indicationsInfo
- Publication number
- ZA978334B ZA978334B ZA978334A ZA978334A ZA978334B ZA 978334 B ZA978334 B ZA 978334B ZA 978334 A ZA978334 A ZA 978334A ZA 978334 A ZA978334 A ZA 978334A ZA 978334 B ZA978334 B ZA 978334B
- Authority
- ZA
- South Africa
- Prior art keywords
- steriod
- ifg
- toxicity
- treatment
- kidney disorders
- Prior art date
Links
- 208000001647 Renal Insufficiency Diseases 0.000 title 1
- 208000017169 kidney disease Diseases 0.000 title 1
- 201000006370 kidney failure Diseases 0.000 title 1
- 230000001988 toxicity Effects 0.000 title 1
- 231100000419 toxicity Toxicity 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71033196A | 1996-09-16 | 1996-09-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA978334B true ZA978334B (en) | 1999-03-16 |
Family
ID=24853590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA978334A ZA978334B (en) | 1996-09-16 | 1997-09-16 | Use of IFG-I for the treatment of kidney disorders renal insufficiencies steriod toxicity and related indications |
Country Status (7)
Country | Link |
---|---|
US (2) | US5985830A (fr) |
EP (1) | EP0956041A1 (fr) |
AR (1) | AR048563A1 (fr) |
AU (1) | AU4196697A (fr) |
CA (1) | CA2265972A1 (fr) |
WO (1) | WO1998011913A1 (fr) |
ZA (1) | ZA978334B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6767892B1 (en) * | 1997-11-07 | 2004-07-27 | Chrion Corporation | Compositions providing for increased IGF-I solubility |
DE60016560T2 (de) * | 1999-01-06 | 2005-12-15 | Genentech, Inc., South San Francisco | Mutierte variante des insulin-ähnlichen wachstumsfaktor-i (igf-i) |
WO2000040612A1 (fr) * | 1999-01-06 | 2000-07-13 | Genentech, Inc. | Variants mutants du facteur de croissance i semblable a l'insuline (igf) |
US6723557B1 (en) | 1999-01-06 | 2004-04-20 | California Institute Of Technology | Caenorhabditis elegans LOV-1 gene |
DK1282437T3 (da) | 2000-05-16 | 2008-06-30 | Genentech Inc | Behandling af brusklidelser |
CA2429615C (fr) * | 2000-11-28 | 2016-07-12 | Children's Medical Center Corporation | Determination des risques et traitement des complications de la prematurite |
US20080090765A1 (en) * | 2006-05-25 | 2008-04-17 | The Trustees Of Columbia University In The City Of New York | Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage |
PT2185662E (pt) | 2007-08-28 | 2011-01-27 | Basf Se | Tio2 fotoactivos em materiais de cobertura |
WO2011149962A1 (fr) | 2010-05-24 | 2011-12-01 | The Trustees Of Columbia University In The City Of New York | Proteines ngal mutantes et leurs utilisations |
WO2014081980A2 (fr) | 2012-11-21 | 2014-05-30 | The Trustees Of Columbia University In The City Of New York | Protéines ngal mutantes et leurs utilisations |
US9457016B2 (en) | 2013-08-29 | 2016-10-04 | New York University | Methods for treating polycystic kidney disease |
WO2019118272A1 (fr) * | 2017-12-11 | 2019-06-20 | Mayo Foundation For Medical Education And Research | Utilisation de probénécide pour traiter la polykystose rénale |
TW202233228A (zh) * | 2020-10-19 | 2022-09-01 | 美商舒爾人類基因療法公司 | 適用於新生兒的組成物 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4485045A (en) * | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
DE3218121A1 (de) * | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
HUT35524A (en) * | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
ATE81779T1 (de) * | 1985-08-22 | 1992-11-15 | Gropep Pty Ltd | Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren. |
SE8505922D0 (sv) * | 1985-12-13 | 1985-12-13 | Kabigen Ab | Construction of an igg binding protein to facilitate downstream processing using protein engineering |
ATE109828T1 (de) * | 1987-04-23 | 1994-08-15 | Monsanto Co | Sekretion eines dem insulin ähnlichen wachstumsfaktors in e. coli. |
JP2507106B2 (ja) * | 1987-12-24 | 1996-06-12 | グロペップ プロプライエタリー リミテッド | インスリン様成長因子1(igf―1)または因子2(igf―2)の類縁ペプチド |
DE68905203T2 (de) * | 1988-02-05 | 1993-07-22 | Ciba Geigy Ag | Verwendung von igf i zur herstellung eines praeparates fuer die behandlung von nierenkrankheiten. |
US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
ZA9010332B (en) * | 1989-12-22 | 1991-08-28 | Ciba Geigy | Method of reducing or preventing adverse effect of steroid therapy and compositions therefor |
US5128320A (en) * | 1990-01-18 | 1992-07-07 | Genentech, Inc. | Method of restoring normal growth, weight gain or lean body mass in patients with glucocorticoid excess by administering igf-i |
TW270116B (fr) * | 1991-04-25 | 1996-02-11 | Hoffmann La Roche | |
RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
JPH05194254A (ja) * | 1992-01-22 | 1993-08-03 | Banyu Pharmaceut Co Ltd | エンドセリンアンタゴニストを含有する抗高脂血症剤 |
CA2133090A1 (fr) * | 1992-04-22 | 1993-10-28 | Wayne L. Cody | Antagoniste ii de l'endoline |
US5273961A (en) * | 1992-09-22 | 1993-12-28 | Genentech, Inc. | Method of prophylaxis of acute renal failure |
TW287160B (fr) * | 1992-12-10 | 1996-10-01 | Hoffmann La Roche | |
CA2126619A1 (fr) * | 1993-06-24 | 1994-12-25 | Yasutaka Igari | Preparation a liberation prolongee d'une substance anti-endotheline |
TW394761B (en) * | 1993-06-28 | 2000-06-21 | Hoffmann La Roche | Novel Sulfonylamino Pyrimidines |
CA2176709A1 (fr) * | 1993-11-15 | 1995-05-26 | Howard R. Higley | Procede de traitment d'affections renales par administration de facteur de croissance insulinoide-i (igf-i) et de proteine-3 fixatrice du facteur de croissance insulinoide (igfbp-3) |
US5565428A (en) * | 1995-05-22 | 1996-10-15 | Genentech, Inc. | Method of administration of IGF-I |
US5741776A (en) * | 1995-05-22 | 1998-04-21 | Genentech, Inc. | Method of administration of IGF-I |
-
1997
- 1997-09-16 WO PCT/CA1997/000666 patent/WO1998011913A1/fr not_active Application Discontinuation
- 1997-09-16 EP EP97939919A patent/EP0956041A1/fr not_active Withdrawn
- 1997-09-16 US US08/933,196 patent/US5985830A/en not_active Expired - Fee Related
- 1997-09-16 AU AU41966/97A patent/AU4196697A/en not_active Abandoned
- 1997-09-16 AR ARP970104233A patent/AR048563A1/es unknown
- 1997-09-16 ZA ZA978334A patent/ZA978334B/xx unknown
- 1997-09-16 CA CA002265972A patent/CA2265972A1/fr not_active Abandoned
-
1999
- 1999-05-07 US US09/307,005 patent/US6071880A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2265972A1 (fr) | 1998-03-26 |
EP0956041A1 (fr) | 1999-11-17 |
US6071880A (en) | 2000-06-06 |
AR048563A1 (es) | 2006-05-10 |
AU4196697A (en) | 1998-04-14 |
WO1998011913A1 (fr) | 1998-03-26 |
US5985830A (en) | 1999-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH31420A (en) | Methods of use for inhibiting bone loss and lowering serum cholesteol. | |
HUP9904361A3 (en) | Use of isobutylgaba and its derivatives for the treatment of pain | |
HUP1500179A2 (en) | The use of human tnf-alpha binding antibodies | |
ZA978334B (en) | Use of IFG-I for the treatment of kidney disorders renal insufficiencies steriod toxicity and related indications | |
IL130485A0 (en) | New treatment for joint inflammation | |
AU5563398A (en) | Use of mifepristone for the treatment of psychoses and addictive behaviours | |
IL125557A0 (en) | Use of lhrh-analogs and anti-estrogens for treating gynaecological disorders | |
EP1030663A4 (fr) | Traitement de fibromyalgie et de troubles qui y sont lies | |
HK1018271A1 (en) | Substituted benzylamines and their use for the treatment of depression | |
AU4347696A (en) | Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases | |
HU9700071D0 (en) | Use of muramilpeptides | |
GB9304658D0 (en) | Flatus filters | |
HK1022267A1 (en) | Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis | |
GB9615159D0 (en) | Treatment of liquid | |
GB9620777D0 (en) | Therapeutic use | |
GB2296660B (en) | Flatus filters | |
GB9416410D0 (en) | Effluent treatment | |
HU9500092D0 (en) | Griddle apparatus for purifiing of wastewater | |
AU4643799A (en) | Hydrocolloids obtained from portulaca oleracea and the use thereof | |
GB9608389D0 (en) | Treatment of spillages | |
GB9611871D0 (en) | Improvements for the use of tissues | |
IL121229A0 (en) | Hydrocolloids obtained from portulaca oleracea and the use thereof | |
GR3030467T3 (en) | Block normalization processor | |
HK1020382A1 (en) | Block normalization processor | |
GB9605523D0 (en) | Therapeutic use |